ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,480.64
      1.34%
      US Tech 100
      18,207.20
      1.45%
      Dow Jones
      40,926.24
      1.44%
      Brent Oil
      71.455
      -0.11%
      Bitcoin
      56,481.69
      2.94%
      Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
      Get Started
      Unknown symbol
      		Date:
      Sort by:
      DateTimeSourceHeadlineSymbolCompany
      1:34PMiHub NewswireFeaturedElement79 Gold Corp. Announces Sale of 100% Interest in Elder Creek, North Mill Creek, and Elephant Projects to 1472886 B.C. Ltd.
      09/09/20241:20PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:PODDInsulet Corporation
      09/09/20241:20PMGlobeNewswire Inc.SVN International Corp. Appoints Lukas Krause as Chief Executive Officer
      09/09/20241:19PMGlobeNewswire Inc.BrandSafway Acquires Covan’s Insulation Company
      09/09/20241:19PMBusiness WireCitizens for a New Delaware Way Slams Double Standard for Bethany Hall-Long, State Rep Candidate Branden Fletcher-Dominguez
      09/09/20241:19PMBusiness WireVitaprotech Group Finalizes Purchase and Merger with Identiv’s Security and Identity Reader Business and Relaunches Iconic Hirsch Brand
      09/09/20241:15PMEdgar (US Regulatory)Form 424B2 - Prospectus [Rule 424(b)(2)]AMEX:WUCTETRACS Whitney US Critical Technologies Index ETN
      09/09/20241:15PMEdgar (US Regulatory)Form 424B2 - Prospectus [Rule 424(b)(2)]USOTC:TDOPFToronto Dominion Bank (PK)
      09/09/20241:15PMPR Newswire (US)Osimertinib With Savolitinib Demonstrates Stronger Efficacy Than Osimertinib Alone in Patients Who Do Not Respond Well to EGFR-TKIs Therapy
      09/09/20241:15PMPR Newswire (US)Aumolertinib Maintenance after Chemoradiotherapy in Stage III Non-Small Cell Lung Cancer Improves PFS Compared to Placebo
      09/09/20241:15PMPR Newswire (US)Breakthrough Therapy BAY 2927088 Demonstrates 'Rapid, Substantial and Durable Responses' in Patients with HER2-Mutant NSCLC
      09/09/20241:15PMPR Newswire (US)Results from the FURTHER Trial Demonstrate Firmonertinib is a Promising Potential Therapy for Patients with NSCLC with EGFR PACC Mutations
      09/09/20241:15PMPR Newswire (US)Uzbekistan's Political Parties Hold Conventions in Run-Up to Midterm Elections
      09/09/20241:14PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:HZOMarineMax Inc
      09/09/20241:14PMBusiness WireSaudi Arabia Showcases Strategic Tourism Investments at IHIF Asia, Opening Doors to Investors
      09/09/20241:13PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:EEFTEuronet Worldwide Inc
      09/09/20241:12PMEdgar (US Regulatory)Form N-CSRS - Certified Shareholder Report, Semi-AnnualNYSE:SPESpecial Opportunities Fund Inc
      09/09/20241:12PMGlobeNewswire Inc.Siebert Williams Shank Expands Taxable Municipal & Corporate Commercial Paper Trading Team
      09/09/20241:12PMBusiness WireNew results from the Investigational agent BAY 2927088 in HER2-mutant non-small cell lung cancer (NSCLC) presented at WCLC
      09/09/20241:11PMEdgar (US Regulatory)Form 424B2 - Prospectus [Rule 424(b)(2)]AMEX:AMJBAlerian Mlp Index ETNs due January 28 2044
      09/09/20241:11PMPR Newswire (US)Employee Benefit News names Elevate's Brian Strom as Outstanding Tech Innovator
      09/09/20241:10PMEdgar (US Regulatory)Form 424B2 - Prospectus [Rule 424(b)(2)]AMEX:WUCTETRACS Whitney US Critical Technologies Index ETN
      09/09/20241:10PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesAMEX:RCGRENN Fund Inc
      09/09/20241:10PMPR Newswire (US)OCCRRA Appoints Christopher Angellatta, Ph.D., as New Chief Executive Officer
      09/09/20241:09PMPR Newswire (US)Uzbekistan's Political Parties Hold Conventions in Run-Up to Midterm Elections
      09/09/20241:07PMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:HBCYFHSBC Holding Plc (PK)
      09/09/20241:07PMEdgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:GYROGyrodyne LLC
      09/09/20241:06PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:SPGCSacks Parente Golf Inc
      09/09/20241:06PMEdgar (US Regulatory)Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectusesAMEX:AMJBAlerian Mlp Index ETNs due January 28 2044
      09/09/20241:06PMEdgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:MASIMasimo Corporation

      Your Recent History

      LSE
      93RV
      Experian Fin 20
      Delayed Upgrade Clock